Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB26FATZB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,099
Award facts
- Contract value 100% obligated
- $10,099.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,099.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder. The contract is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and will be performed in Conshohocken, PA. This award carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, and registered in the System for Award Management since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, valued at up to $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. The company's extensive product portfolio and demonstrated performance across multiple therapeutic categories positions it as a significant contributor to military medical supply operations worldwide.
Quick answers
Who was awarded contract SPE2DB26FATZB?
SPE2DB26FATZB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FATZB worth?
The government has obligated $10,099 on SPE2DB26FATZB.
Is contract SPE2DB26FATZB an order under another contract?
Yes. SPE2DB26FATZB is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZB competed?
The extent of competition for SPE2DB26FATZB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award